Tag Archives: Biologics by McKesson

Specialty Pharmacy News Roundup: March 2023

AMI’s Specialty Pharmacy Database continually monitors and tracks all limited and exclusive pharmacy distribution agreements

Specialty Pharmacy Limited Distribution Drug Agreements at Year-End 2022

The leading specialty pharmacies were busy signing limited distribution drug agreements at the end of 2022. Here’s a round-up of the activities

Biologics by McKesson Selected to Provide VONJO and PYRUKYND

Biologics by McKesson continues to solidify its leadership position a provider for limited and exclusive drugs in the specialty pharmacy market

Biologics Selected by Agios Pharmaceuticals as Exclusive Distributor of PYRUKYND®

PYRUKYND prescriptions are processed exclusively through Biologics by McKesson to give patients a seamless experience

Biologics by McKesson Starting the New Year With Momentum

Biologics by McKesson, selected as a specialty pharmacy distributor for three specialty drugs recently, is starting the new year with momentum

Biologics by McKesson Selected to Provide TRUSELTIQ and LUMAKRAS

Biologics specialty pharmacy teams includes pharmacists with in-depth knowledge of therapies, experienced nurses, and financial counselors who are familiar with various financial assistance programs and organizations that help patients

Biologics by McKesson Expands Oncology Practices Offerings

Biologics has contracted with more than 500 payers and offers more than 150 therapies

AVEO Oncology’s Limited Specialty Pharmacy Distribution Network for Fotivda Selected

Biologics by McKesson and Onco360 continue to solidify their positions as market-leading specialty pharmacy providers of oncology drugs